Radar · Biopharma Outsourcing in United States
Best Biopharma Outsourcing Companies in United States
The 2542 best Biopharma Outsourcing companies in United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Resilience.
By Riya SenguptaFinancials
2542companies tracked
$20.3Bdisclosed funding
1unicorns
558have raised
Ranked by disclosed equity funding and recent funding momentum, this directory maps 2,542 Biopharma Outsourcing companies operating across the United States, with $20.3B in total disclosed funding behind them. That's real capital, and the revenue picture underneath it is just as serious.
Across 24 validated filers, median revenue sits at $310M with a combined pool of $12.2B, growing at a modest 5% clip. But median obscures the spread. Xylem Inc. pulled $2.1B in revenue, PPD, Inc. posted $1.4B at a sharp 29% growth rate, and Catalent, Inc. cleared $1.0B. On the profit side, Xylem's $193M net income runs 11x the sector median of $18M. And if you're wondering where the outsized funding sits, Resilience alone accounts for $2.0B of the directory total. So the sector isn't uniformly rich, it's stratified. I'd pay close attention to the clinical trial outsourcing and viral vector vaccine themes right now, because that's where filer momentum is concentrating, even as broader analyst coverage stays flat. The one unicorn in the mix tells you the ceiling exists, even if most of the 2,542 tracked here are still building toward it.
Sources & further reading
- ‘West Asia conflict effect kept in mind’: Cabinet clears 12% hike in P&K fertili
- Finance’s bare minimum approach to local companies
- At the Leading Edge of Defence Innovation
FLIAR INTELLIGENCE · BIOPHARMA OUTSOURCING × UNITED STATES
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
77%cloud-native stacks
2025funding peak (by rounds)
2018median founding year
45median Fliar Index™
1.3Mcombined LinkedIn audience
73%of audience held by top 3
10companies hiring publicly (12 mo)
Ranked: Best Biopharma Outsourcing companies in United States
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Resilience Provider of supply chain services for biopharma sector 72Funding top 15%Product top 26%Innovation top 30%Growth top 35% All 9 signals ▾Fundingtop 15% Producttop 26% Innovationtop 30% Growthtop 35% Markettop 43% Techtop 43% Talentbottom 49% Globalbottom 38% Moatbottom 38% Funding: Raised $2.0B across 10 rounds · 10 rounds over 20 yrs (0.5/yr) Product: 3 distinct product lines · Company stage: Series D rank vs industry peers · Fliar Intelligence Index 72/100 | $2.0B | 7 mo ago | 1,767 | Rahul Singhvi ex-Co-Founder | HubSpot CMS HubApple iCloud MailMicrosoft 365+23 | — | — | 1 expansion |
| 2 | PPD CRO providing diversified clinical development services 87Funding top 18%Fin. health top 19%Market top 23%Moat top 34% All 8 signals ▾Fundingtop 18% Fin. healthtop 19% Markettop 23% Moattop 34% Techtop 38% Growthbottom 48% Globalbottom 46% Newsbottom 35% Funding: Raised $1.0B across 5 rounds · 5 rounds over 3 yrs (1.7/yr) Fin. health: Revenue ~$4.7B (FY2021) · Net margin 10.7% rank vs industry peers · Fliar Intelligence Index 87/100 | $1.0B | 32 mo ago | 1,530 | — | WordPress Block EditorWordPressMySQL+27 | — | — | — |
| 3 | Kardigan Biotech company developing personalized medicines for cardiovascular diseases 60Funding top 14%Growth top 28%Tech top 48%Talent bottom 49% All 6 signals ▾Fundingtop 14% Growthtop 28% Techtop 48% Talentbottom 49% Marketbottom 35% Globalbottom 33% Funding: Raised $554M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $554M | 8 mo ago | — | Tassos Gianakakos Co-Founder & CEO | WordPressApple iCloud MailMicrosoft 365+25 | — | — | 1 job opening · 1 internship |
| 4 | Caidya CRO focused on clinical development for phases II & III clinical trials and regulatory affair services 50Funding top 20%Tech top 48%Growth bottom 45%Market bottom 44% All 7 signals ▾Fundingtop 20% Techtop 48% Growthbottom 45% Marketbottom 44% Moatbottom 38% Globalbottom 37% Newsbottom 21% Funding: Raised $373M across 5 rounds · 5 rounds over 10 yrs (0.5/yr) Tech: 25 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 50/100 | $373M | 17 mo ago | 351 351 → 748 (+113%) · sector median +27% | — | WordPressMySQLPHP+22 | — | — | 1 partnership · 2 awards |
| 5 | Surrozen Pioneering targeted regenerative antibodies to repair tissue and restore organ function 19Product top 14%Funding top 24%News top 33%Moat top 41% All 11 signals ▾Producttop 14% Fundingtop 24% Newstop 33% Moattop 41% Innovationtop 48% Patentstop 48% Growthbottom 46% Globalbottom 40% Marketbottom 29% Fin. healthbottom 20% Techbottom 15% Product: 11 distinct product lines · Company stage: Public Funding: Raised $326M across 5 rounds · 5 rounds over 9 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 19/100 | $326M | 14 mo ago | 80 | — | — | 22 signals ▲1000% Acquisition · Leadership | 37 patents Wnt pathway biologics and modulators for ocular and tissue regeneration therapies | — |
| 6 | Lifecore Sterile injectable CDMO and sodium hyaluronate producer, advancing pharmaceutical possibilities 60Product top 19%Funding top 20%Innovation top 30%Tech top 38% All 11 signals ▾Producttop 19% Fundingtop 20% Innovationtop 30% Techtop 38% Markettop 46% Fin. healthtop 49% Moatbottom 42% Growthbottom 41% Partnersbottom 35% Newsbottom 33% Globalbottom 32% Product: 3 distinct product lines · Company stage: Public Funding: Raised $269M across 4 rounds · 4 rounds over 4 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 60/100 | $269M | 20 mo ago | 459 459 → 275 (-40%) · sector median +27% | — | WordPressMySQLPHP+28 | — | — | — |
| 7 | Kashiv BioSciences Developer of biosimilar medicines 76Innovation top 12%Patents top 17%News top 20%Partners top 21% All 10 signals ▾Innovationtop 12% Patentstop 17% Newstop 20% Partnerstop 21% Fundingtop 24% Talenttop 27% Growthtop 30% Marketbottom 49% Globalbottom 41% Techbottom 39% Innovation: 284 patents (top 8% of patent-holders) · 188 filings since 2022 vs 95 in 2017-21 Patents: 284 patents matched (strict assignee match) · 188 filings since 2022 vs 95 in 2017-21 rank vs industry peers · Fliar Intelligence Index 76/100 | $222M | 5 mo ago | 235 | Chintu Patel Co-Founder | WebflowLenisjQuery+11 | 12 signals ▲100% Leadership · Contracts · Funding | 284 patents Protein purification and formulation technologies for therapeutic antibodies and small‑molecule drugs. | — |
| 8 | PCI Provider of clinical & commercial supply chain and packaging solutions 84Funding top 22%Tech top 24%Innovation top 25%Product top 30% All 8 signals ▾Fundingtop 22% Techtop 24% Innovationtop 25% Producttop 30% Growthtop 35% Markettop 38% Talentbottom 49% Globalbottom 38% Funding: Raised $205M across 1 rounds · 1 rounds over 14 yrs (0.1/yr) Tech: 48 technologies across 5/8 capability areas · Cloud: Amazon Ses, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 84/100 | $205M | 11 mo ago | 4,300 | Salim Haffar CEO | Craft CMSApple iCloud MailPHP+26 | — | — | 2 expansions |
| 9 | Superluminal Medicines Generative biological and chemical company focused on drug discovery 57Funding top 21%Talent top 38%Market bottom 44%Partners bottom 35% All 6 signals ▾Fundingtop 21% Talenttop 38% Marketbottom 44% Partnersbottom 35% Globalbottom 29% Newsbottom 15% Funding: Raised $153M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 57/100 | $153M | 10 mo ago | — | Ajay Yekkirala Co-Founder | — | — | — | — |
| 10 | Alloy Therapeutics Provider of drug discovery services 60Funding top 20%News top 32%Growth top 37%Tech top 39% All 8 signals ▾Fundingtop 20% Newstop 32% Growthtop 37% Techtop 39% Talentbottom 49% Marketbottom 38% Moatbottom 38% Globalbottom 37% Funding: Raised $117M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) News: 3 BI events in 12 mo (of 14 tracked, 5 types) · Top themes: Funding, Capital raise, M&A rank vs industry peers · Fliar Intelligence Index 60/100 | $117M | 2 mo ago | 130 | Errik Anderson CEO | WordPressApple iCloud MailGoogle Workspace+32 | 3 signals Capital raise · M&A · Funding | — | 1 job opening · 1 partnership |
| 11 | Phlow CDMO focused on manufacturing of API products for biopharma sector 42Growth top 35%Funding top 38%Tech top 38%News top 43% All 7 signals ▾Growthtop 35% Fundingtop 38% Techtop 38% Newstop 43% Talentbottom 40% Marketbottom 25% Globalbottom 25% Growth: Fresh capital in last 24 mo Funding: Raised $85.2M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 42/100 | $85M | 16 mo ago | 55 | Eric Edwards Md Co-Founder and CEO | WordPressApple iCloud MailMySQL+28 | — | — | 1 award |
| 12 | SpectronRx Provider of therapeutic and diagnostic isotope solutions 45Funding top 21%Growth top 28%Moat top 45%News top 46% All 11 signals ▾Fundingtop 21% Growthtop 28% Moattop 45% Newstop 46% Markettop 47% Talentbottom 49% Patentsbottom 41% Techbottom 37% Globalbottom 35% Partnersbottom 35% Innovationbottom 23% Funding: Raised $85.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 45/100 | $85M | 2 mo ago | 93 | John Zehner CEO | WordPressMySQLPHP+14 | — | 2 patents Radium‑226 extraction from phosphogypsum waste streams | — |
| 13 | InduPro Provides science to manipulate protein interactions and explore new possibilities for treating patients 21Funding top 29%Tech bottom 40%Global bottom 36%Market bottom 22% All 4 signals ▾Fundingtop 29% Techbottom 40% Globalbottom 36% Marketbottom 22% Funding: Raised $85.0M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) Tech: 20 technologies across 2/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 21/100 | $85M | 6 mo ago | 34 | — | WordPressMySQLPHP+17 | — | — | 1 partnership |
| 14 | Indapta Limited information available 55Funding top 31%Global bottom 48% All 2 signals ▾Fundingtop 31% Globalbottom 48% Funding: Raised $72.8M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) Global: Investors from 2 countries beyond United States rank vs industry peers · Fliar Intelligence Index 55/100 | $73M | 18 mo ago | 14 | — | — | — | — | — |
| 15 | Tenpoint Therapeutics Developer of engineered cell-based therapeutics to restore vision 50Funding top 23%Talent top 23%Moat top 31%Growth top 33% All 8 signals ▾Fundingtop 23% Talenttop 23% Moattop 31% Growthtop 33% Techtop 49% Newstop 49% Globalbottom 39% Marketbottom 26% Funding: Raised $70.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Talent: 8 named leaders on record · 8 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 50/100 | $70M | 4 mo ago | 14 | Jose Sahel Co-Founder | WordPressMySQLMariaDB+25 | 3 signals ▲50% Funding | — | — |
| 16 | Wheeler Bio Provider of drug research and analytical development services for multiple therapeutic areas 42Funding top 29%Tech top 36%Growth top 45%Global bottom 38% All 6 signals ▾Fundingtop 29% Techtop 36% Growthtop 45% Globalbottom 38% Marketbottom 24% Newsbottom 18% Funding: Raised $68.2M across 4 rounds · 4 rounds over 4 yrs (1.0/yr) Tech: 36 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 42/100 | $68M | 15 mo ago | 42 | — | WordPress Block EditorWordPressMySQL+32 | — | — | 1 expansion |
| 17 | Rho Full and functional service CRO offering clinical development services 57Funding top 35%Growth top 35%News top 40%Tech top 45% All 7 signals ▾Fundingtop 35% Growthtop 35% Newstop 40% Techtop 45% Markettop 49% Globalbottom 37% Productbottom 36% Funding: Raised $67.5M across 9 rounds · 9 rounds over 12 yrs (0.8/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 57/100 | $67M | 13 mo ago | 859 | — | WordPressApple iCloud MailMySQL+24 | — | — | — |
| 18 | Hyku Biosciences Covalent medicines platform for expanding the boundaries of drug discovery 57Funding top 33%Talent bottom 49%Global bottom 38%News bottom 18% All 4 signals ▾Fundingtop 33% Talentbottom 49% Globalbottom 38% Newsbottom 18% Funding: Raised $56.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 57/100 | $56M | 6 mo ago | — | Kleem Chaudhary President & Chief Executive Officer | — | — | — | — |
| 19 | Manifold Bio Developer of tissue-targeted therapeutics using in vivo screening and AI design 29Funding top 34%Talent top 45%Moat bottom 38%Global bottom 37% All 5 signals ▾Fundingtop 34% Talenttop 45% Moatbottom 38% Globalbottom 37% Marketbottom 26% Funding: Raised $45.4M across 3 rounds · 3 rounds over 6 yrs (0.5/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 29/100 | $45M | 18 mo ago | 22 | Gleb Kuznetsov Co-Founder & CEO | — | — | — | — |
| 20 | Javara Research Integrating clinical research at the point of care for better outcomes 50Funding top 31%Growth top 35%Tech top 43%Moat top 48% All 8 signals ▾Fundingtop 31% Growthtop 35% Techtop 43% Moattop 48% Talentbottom 49% Marketbottom 41% Globalbottom 29% Newsbottom 21% Funding: Raised $40.0M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 50/100 | $40M | 13 mo ago | 233 | Jennifer Byrne CEO | WordPressApple iCloud MailMicrosoft 365+26 | — | — | 1 award |
| 21 | Inceptor CDMO offering services for cell and gene therapy products 7Funding top 47%Moat bottom 42%Global bottom 35%Market bottom 34% All 7 signals ▾Fundingtop 47% Moatbottom 42% Globalbottom 35% Marketbottom 34% Patentsbottom 31% Newsbottom 21% Innovationbottom 4% Funding: Raised $37.7M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) Moat: Editorial + unicorn rating 1/10 · IP moat: 2 patents rank vs industry peers · Fliar Intelligence Index 7/100 | $38M | 17 mo ago | 69 | — | — | — | 2 patents Accelerating web page delivery and enriching data indexing for e‑commerce platforms | — |
| 22 | Ember LifeSciences Provider of cold chain logistics services for biopharma sector 35Patents top 28%Funding top 32%Innovation top 34%News top 39% All 9 signals ▾Patentstop 28% Fundingtop 32% Innovationtop 34% Newstop 39% Moattop 45% Techbottom 46% Globalbottom 40% Talentbottom 40% Marketbottom 16% Patents: 28 patents matched (strict assignee match) · 26 filings since 2022 vs 2 in 2017-21 Funding: Raised $37.4M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $37M | 0 mo ago | — | Clay Alexander Founder & Chairman | WixSentryBootstrap+10 | 3 signals Funding · Leadership | 28 patents Temperature‑controlled reusable shipping containers for biotech/medical sample transport | 1 job opening · 3 launchs · 1 award |
| 23 | Kincell Bio Provider of clinical cell therapy development & manufacturing and consulting services 55Funding top 36%Growth top 38%Talent top 46%News bottom 48% All 6 signals ▾Fundingtop 36% Growthtop 38% Talenttop 46% Newsbottom 48% Marketbottom 44% Globalbottom 29% Funding: Raised $36.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 55/100 | $36M | 13 mo ago | — | Bruce Thompson CTO | — | 3 signals Leadership | — | — |
| 24 | Liberation Labs CRO focused on providing fermentation products manufacturing and commercialisation services 22Funding top 29%Talent top 38%Growth bottom 42%Global bottom 37% All 7 signals ▾Fundingtop 29% Talenttop 38% Growthbottom 42% Globalbottom 37% Techbottom 30% Newsbottom 21% Marketbottom 17% Funding: Raised $36.0M across 6 rounds · 6 rounds over 4 yrs (1.5/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 22/100 | $36M | 16 mo ago | 13 | Etan Bendheim Co-Founder & Chief Business Officer | WordPressMySQLPHP+15 | — | — | — |
| 25 | GBI Provider of contract based drug manufacturing, regulatory support, and quality assurance services 42Funding top 31%Growth top 43%Tech top 45%Talent bottom 49% All 7 signals ▾Fundingtop 31% Growthtop 43% Techtop 45% Talentbottom 49% Globalbottom 32% Marketbottom 27% Newsbottom 22% Funding: Raised $25.7M across 4 rounds · 4 rounds over 7 yrs (0.6/yr) Growth: Headcount 61 → 62 (+2%) across vintages · Web rank 50,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 42/100 | $26M | 6 mo ago | 62 62 → 89 (+44%) · sector median +27% | Darrin Schellin Chief Executive Officer | WordPressApple iCloud MailMicrosoft 365+20 | — | — | — |
| 26 | Oryon Developer of autologous neuron replacement medicines for neurodegenerative disorders 50Talent top 28%Funding top 45%Innovation top 49%Patents top 49% All 5 signals ▾Talenttop 28% Fundingtop 45% Innovationtop 49% Patentstop 49% Globalbottom 42% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $21.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 50/100 | $21M | 2 mo ago | — | Ole Isacson Co-Founder | — | — | 20 patents Electroluminescent lighting and flexible EL display technologies with nano‑engineered phosphor layers | — |
| 27 | GSSHealth Provider of data management, logistics and training services 60Innovation top 36%Funding top 42%Product top 46%Tech bottom 45% All 5 signals ▾Innovationtop 36% Fundingtop 42% Producttop 46% Techbottom 45% Globalbottom 33% Innovation: 12 product lines Funding: Raised $18.2M across 7 rounds · 7 rounds over 8 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 60/100 | $18M | 13 mo ago | — | — | — | — | — | — |
| 28 | BlueWhale Provider of cell & gene therapies development and research services 45Growth top 28%Funding top 38%Talent top 38%Tech top 43% All 7 signals ▾Growthtop 28% Fundingtop 38% Talenttop 38% Techtop 43% Newstop 46% Globalbottom 36% Marketbottom 22% Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Funding: Raised $18.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $18M | 8 mo ago | — | Carl June Founder | WordPressMySQLPHP+27 | — | — | 1 job opening |
| 29 | Dash Bio Provider of automated bioanalysis platform for accelerated clinical drug development 40Talent top 38%Funding top 39%Global bottom 33% All 3 signals ▾Talenttop 38% Fundingtop 39% Globalbottom 33% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $17.5M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 40/100 | $18M | 12 mo ago | — | Ander Tallett Co-Founder & COO | — | — | — | — |
| 30 | XDemics CDMO focused on manufacturing cell & viral based therapeutics 50Funding top 38%Tech top 45%Talent bottom 49%Global bottom 25% All 4 signals ▾Fundingtop 38% Techtop 45% Talentbottom 49% Globalbottom 25% Funding: Raised $14.8M across 3 rounds · 3 rounds over 2 yrs (1.5/yr) Tech: 30 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 50/100 | $15M | 7 mo ago | — | Christopher Thanos CEO & Chairman | WebflowGSAPLenis+15 | — | — | 1 partnership |
| 31 | TissueVision Innovating whole tissue imaging and analysis solutions for life-saving therapies 22Patents top 40%Funding top 43%Moat top 45%Innovation top 48% All 7 signals ▾Patentstop 40% Fundingtop 43% Moattop 45% Innovationtop 48% Techbottom 42% Globalbottom 37% Marketbottom 26% Patents: 41 patents matched (strict assignee match) · 9 filings since 2022 vs 15 in 2017-21 Funding: Raised $13.4M across 15 rounds · 15 rounds over 17 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 22/100 | $13M | 12 mo ago | 17 | — | — | — | 41 patents Automated digital pathology: tissue section handling, indexing, multiplex imaging, and serial staining. | — |
| 32 | Fauna Bio Healthcare association involved in animal genomics 24Talent top 38%Funding top 41%Global bottom 39%Moat bottom 38% All 6 signals ▾Talenttop 38% Fundingtop 41% Globalbottom 39% Moatbottom 38% Techbottom 36% Marketbottom 23% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $13.1M across 6 rounds · 6 rounds over 7 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $13M | 14 mo ago | 15 15 → 22 (+47%) · sector median +27% | Ashley Zehnder Co-Founder & CEO | WebflowcdnjsjsDelivr+7 | — | — | — |
| 33 | revalia bio Provider of contract based drugs development services for biopharma sector 40Talent top 23%Growth top 35%Funding top 39%Tech bottom 46% All 7 signals ▾Talenttop 23% Growthtop 35% Fundingtop 39% Techbottom 46% Moatbottom 38% Globalbottom 29% Marketbottom 14% Talent: 5 named leaders on record · 5 C-suite/founder profiles curated Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $12M | 9 mo ago | 3 | Shohei Koide Co-Founder | TurbopackNode.jsTailwind CSS+11 | — | — | 2 partnerships |
| 34 | Acclinate Provider of clinical trial services to biopharma sector 9Funding top 38%News top 43%Moat bottom 44%Patents bottom 37% All 7 signals ▾Fundingtop 38% Newstop 43% Moatbottom 44% Patentsbottom 37% Globalbottom 33% Marketbottom 30% Innovationbottom 23% Funding: Raised $12.0M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) News: 2 BI events in 12 mo (of 6 tracked, 4 types) · Top themes: Announcements rank vs industry peers · Fliar Intelligence Index 9/100 | $12M | 4 mo ago | 33 | — | — | — | 2 patents Automated patient eligibility assessment and recruitment for clinical trials | — |
| 35 | Cayman Chem Develops bioreagents and offers preclinical services 45Growth top 40%Funding top 42%Tech top 49%Market bottom 49% All 6 signals ▾Growthtop 40% Fundingtop 42% Techtop 49% Marketbottom 49% Talentbottom 45% Globalbottom 32% Growth: Headcount 292 → 309 (+6%) across vintages · Fresh capital in last 24 mo Funding: Raised $8.6M across 6 rounds · 6 rounds over 5 yrs (1.2/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $9M | 11 mo ago | 309 309 → 267 (-14%) · sector median +27% | Kirk Maxey Owner | Cart FunctionalityAmazon Web ServicesAzure+12 | — | — | 2 launchs |
| 36 | Abbratech CRO focused on providing antibody discovery & development services 27Funding top 35%Patents top 36%Innovation top 37%Moat bottom 49% All 6 signals ▾Fundingtop 35% Patentstop 36% Innovationtop 37% Moatbottom 49% Globalbottom 31% Marketbottom 14% Funding: Raised $8.5M across 11 rounds · 11 rounds over 3 yrs (3.7/yr) Patents: 16 patents matched (strict assignee match) · 16 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 27/100 | $9M | 11 mo ago | 9 | — | — | — | 16 patents Engineered antibodies: site‑specific conjugation, ligand‑directed design, optimized IgG, pan‑variant therapeutics | — |
| 37 | Afaxys Affordable sexual and reproductive healthcare access for all, mission-driven 37Innovation top 20%Talent top 41%Product top 43%News top 46% All 8 signals ▾Innovationtop 20% Talenttop 41% Producttop 43% Newstop 46% Fundingbottom 48% Techbottom 38% Globalbottom 32% Marketbottom 24% Innovation: 8 product lines Talent: Analyst team rating 4/5 · 1 named leader on record rank vs industry peers · Fliar Intelligence Index 37/100 | $8M | 10 mo ago | 39 39 → 43 (+10%) · sector median +27% | Ronda Dean Founder & CEO | WordPressPleskApple iCloud Mail+18 | — | — | — |
| 38 | Simulations Plus Developer of modeling and simulation software and consulting services provider 62News top 24%Product top 24%Funding top 28%Fin. health top 33% All 11 signals ▾Newstop 24% Producttop 24% Fundingtop 28% Fin. healthtop 33% Growthtop 37% AItop 45% Techtop 48% Moattop 49% Innovationbottom 48% Marketbottom 47% Globalbottom 37% News: 19 BI events in 12 mo (of 179 tracked, 10 types) · +111% YoY Product: 1 product launch event in 12 mo · 6 distinct product lines rank vs industry peers · Fliar Intelligence Index 62/100 | $8M | 11 mo ago | 197 197 → 197 (+0%) · sector median +27% | — | WordPressApple iCloud MailMicrosoft 365+26 | 19 signals ▲90% Earnings · New product | — | 1 job opening · 1 launch · 1 partnership |
| 39 | Exela Pharma Manufacturer of sterile injectable pharmaceutical products and CDMO services 48Innovation top 20%Product top 30%Growth top 40%Funding top 43% All 8 signals ▾Innovationtop 20% Producttop 30% Growthtop 40% Fundingtop 43% Talentbottom 49% Marketbottom 37% Globalbottom 32% Techbottom 31% Innovation: 8 product lines Product: 8 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 48/100 | $7M | 8 mo ago | 205 205 → 339 (+65%) · sector median +27% | Phanesh Koneru Co-Founder & CEO | WordPressMySQLPHP+17 | — | — | 2 job openings · 1 award |
| 40 | New Iridium Manufacturer of phenoxazine and dihydrophenazine 24Talent top 28%Funding top 39%Global bottom 29%Market bottom 19% All 4 signals ▾Talenttop 28% Fundingtop 39% Globalbottom 29% Marketbottom 19% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $6.1M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $6M | 12 mo ago | 11 | Garrett Miyake Co-Founder & CTO | — | — | — | — |
| 41 | Lifordi Biotechnology company developing treatments for autoimmune and inflammatory disorders using antibody-drug… 45Funding top 45%Talent bottom 49%Global bottom 36% All 3 signals ▾Fundingtop 45% Talentbottom 49% Globalbottom 36% Funding: Raised $5.9M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 45/100 | $6M | 6 mo ago | — | Arthur Tzianabos CEO | — | — | — | — |
| 42 | Tri-Pac Offers contract manufacturing, filling and packaging services 50Growth top 35%Innovation top 36%Product top 43%Funding bottom 49% All 7 signals ▾Growthtop 35% Innovationtop 36% Producttop 43% Fundingbottom 49% Techbottom 48% Globalbottom 36% Marketbottom 31% Growth: Fresh capital in last 24 mo Innovation: 4 product lines rank vs industry peers · Fliar Intelligence Index 50/100 | $6M | 3 mo ago | 122 | — | Wix eCommerceWixSentry+12 | — | — | — |
| 43 | Clinical Trial Research Network of research sites providing clinical trial management services 29Funding top 41%Talent bottom 49%Global bottom 33% All 3 signals ▾Fundingtop 41% Talentbottom 49% Globalbottom 33% Funding: Raised $5.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 29/100 | $5M | 6 mo ago | — | Adarsh Karanth Founder Director | — | — | — | — |
| 44 | Trial Library Provider of clinical trial for drug research & development services 29Growth top 35%Funding top 43%Tech top 50%Global bottom 36% All 5 signals ▾Growthtop 35% Fundingtop 43% Techtop 50% Globalbottom 36% Marketbottom 13% Growth: Fresh capital in last 24 mo Funding: Raised $5.0M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 29/100 | $5M | 6 mo ago | 9 | — | MUIReactReact Router+14 | — | — | 1 job opening |
| 45 | BioMADE Provider of clinical trial research site services for biopharma sector 50Growth top 35%Tech top 36%Funding top 44%Market bottom 33% All 6 signals ▾Growthtop 35% Techtop 36% Fundingtop 44% Marketbottom 33% Globalbottom 32% Newsbottom 21% Growth: Fresh capital in last 24 mo Tech: 31 technologies across 4/8 capability areas · Cloud: Amazon Cloudfront, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 50/100 | $5M | 9 mo ago | 71 | — | Apple iCloud MailRubyTrix+16 | — | — | 1 launch |
| 46 | Protein Dynamic Solutions Transforming protein analytics for better biotherapeutics, enhancing regulatory compliance 42Patents top 25%Innovation top 26%Talent top 28%Moat top 32% All 7 signals ▾Patentstop 25% Innovationtop 26% Talenttop 28% Moattop 32% Fundingtop 48% Globalbottom 35% Marketbottom 14% Patents: 55 patents matched (strict assignee match) · 34 filings since 2022 vs 21 in 2017-21 Innovation: 55 patents (top 29% of patent-holders) · 34 filings since 2022 vs 21 in 2017-21 rank vs industry peers · Fliar Intelligence Index 42/100 | $4M | 10 mo ago | 9 | William Lockwood-Benet Co-Founder | — | — | 55 patents Analytical methods for protein deamidation, immunogenicity, purity, and epitope mapping | 1 launch |
| 47 | DNA Nanobots Biotech company that uses nanotechnology to deliver targeted chemotherapy, vaccines, and gene therapy 19Talent top 38%Funding bottom 44%Global bottom 25%Tech bottom 18% All 4 signals ▾Talenttop 38% Fundingbottom 44% Globalbottom 25% Techbottom 18% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $3.5M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 19/100 | $4M | 6 mo ago | — | Melika Shahhosseini Co-Founder | PHPMediaElement.jsApache HTTP Server+9 | — | — | — |
| 48 | US Pharmatech Producer of nutraceuticals and dietary supplements for global brands 40Patents top 35%Growth top 45%Innovation top 47%Funding top 49% All 7 signals ▾Patentstop 35% Growthtop 45% Innovationtop 47% Fundingtop 49% Globaltop 49% Talentbottom 45% Techbottom 19% Patents: 45 patents matched (strict assignee match) · 16 filings since 2022 vs 27 in 2017-21 Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $3M | 5 mo ago | — | Dongjun Lee Chief Executive Officer | GnuboardMySQLPHP+11 | — | 45 patents Neuropsychiatric drug formulations for dementia, Alzheimer’s, Parkinson’s, anxiety, depression, insomnia | — |
| 49 | Tharimmune Clinical-stage biotechnology company developing a portfolio of therapeutic candidates for rare, inflammatory… 14Growth top 27%Funding top 36%Talent top 38%News top 40% All 10 signals ▾Growthtop 27% Fundingtop 36% Talenttop 38% Newstop 40% Moatbottom 42% Globalbottom 39% Patentsbottom 34% Techbottom 22% Marketbottom 9% Innovationbottom 4% Growth: 3 acquisition/expansion moves in 24 mo · Fresh capital in last 24 mo Funding: Raised $2.1M across 4 rounds · 4 rounds over 2 yrs (2.0/yr) rank vs industry peers · Fliar Intelligence Index 14/100 | $2M | 7 mo ago | 1 | Randy Milby CEO | WordPressMySQLPHP+13 | 11 signals ▲38% Leadership · Funding · Earnings | 2 patents Nanoparticle-based drug delivery systems for immunotherapeutic applications | 1 launch |
| 50 | CubeWorks Provider of millimeter-scale wireless sensors 14Funding top 43%Talent bottom 49%Global bottom 37%Market bottom 24% All 4 signals ▾Fundingtop 43% Talentbottom 49% Globalbottom 37% Marketbottom 24% Funding: Raised $1.1M across 8 rounds · 8 rounds over 10 yrs (0.8/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 14/100 | $1M | 3 mo ago | 14 | Gyouho Kim Chief Executive Officer | — | — | — | — |
Top 12 Biopharma Outsourcing companies in United States
#1
Series D · San Diego, California · founded 1995 · 1767 employees$2Braised▾
Series D · San Diego, California · founded 1995 · 1767 employees
Provider of supply chain services for biopharma sector
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Funding
top 15%Product
top 26%Innovation
top 30%Growth
top 35%Market
top 43%Tech
top 43%Funding: Raised $2.0B across 10 rounds · 10 rounds over 20 yrs (0.5/yr) · Last round Venture Debt (Oct 2025)
Product: 3 distinct product lines · Company stage: Series D
Innovation: 3 product lines
Audience (LinkedIn): 49k LinkedIn followers — 3.8% of this cohort's audience
Activity (LinkedIn): 1 expansions announced in 12 mo
Funding rounds
- Oct 2025Venture Debt$825M
- Oct 2024Grant (prize money)$17.5M
- Mar 2023Conventional Debt$410M
- Jan 2023Series D—
Founders & team
Investors
Mubadala, Kennet Partners, BPEA, Defense.gov, DFC, Arch Venture Partners
Tech stack
Amazon Web ServicesApple Icloud MailCdnjsCloudflareCloudflare Bot ManagementCore-Js
#2
Series E · Lexington, Massachusetts · founded 2017 · 130 employees$117Mraised▾
Series E · Lexington, Massachusetts · founded 2017 · 130 employees
Provider of drug discovery services
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 20%News
top 32%Growth
top 37%Tech
top 39%Talent
bottom 49%Market
bottom 38%Funding: Raised $117M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) · Last round Series E (Mar 2026)
News: 3 BI events in 12 mo (of 14 tracked, 5 types) · Top themes: Funding, Capital raise, M&A
Growth: 1 acquisition/expansion move in 24 mo · Fresh capital in last 24 mo
Audience (LinkedIn): 26k LinkedIn followers — 2.0% of this cohort's audience · 60 engagements/post (2.0× cohort median)
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Director, Partnerships Office
Activity (LinkedIn): 1 partnerships (incl. Voro Therapeutics) announced in 12 mo
Funding rounds
- Mar 2026Series E$40M
- Oct 2022Series D$42M
- Apr 2021Series C$75M
Founders & team
Investors
8VC, Presight Capital, Mubadala, Alexandria, Founders Fund, Ulysses Diversified Holdings
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementCookiebotCore-JsDocusign
#3
Series B · San Francisco, California · founded 2023$554Mraised▾
Series B · San Francisco, California · founded 2023
Biotech company developing personalized medicines for cardiovascular diseases. It is a biotechnology company focused on developing precision medicines for cardiovascular disease. The company aims to modernize cardiovascular drug development with a late-stage portfolio of personalized medicines.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 14%Growth
top 28%Tech
top 48%Talent
bottom 49%Market
bottom 35%Global
bottom 33%Funding: Raised $554M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) · Last round Series B (Oct 2025)
Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo
Tech: 30 technologies across 3/8 capability areas · Cloud: Cloudflare · Security: Cloudflare Bot Management, Http/3
Audience (LinkedIn): 9k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: clinical trial leads, biostatistics experts
Funding rounds
- Oct 2025Series B$254M
- Jan 2025Series A$300M
Founders & team
Investors
Perceptive Advisors, Arch Venture Partners, Sequoia Heritage, Fidelity Investments, T. Rowe Price
Tech stack
AccessibeApple Icloud MailCloudflareCloudflare Bot ManagementDiviDocusign
#4
Series C · Indianapolis, Indiana · founded 2004 · 93 employees$85Mraised▾
Series C · Indianapolis, Indiana · founded 2004 · 93 employees
SpectronRx is a provider of therapeutic and diagnostic isotope solutions. It provides radionuclides and custom theranostic contract manufacturing like monoclonal antibody labelling, peptides, radiolabeling of molecules and chemical entities, and aptamers.
Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 21%Growth
top 28%Moat
top 45%News
top 46%Market
top 47%Talent
bottom 49%Funding: Raised $85.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series C (Apr 2026)
Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Moat: Editorial + unicorn rating 4/10 · IP moat: 2 patents
Audience (LinkedIn): 7k LinkedIn followers
Funding rounds
- Apr 2026Series C$85M
Founders & team
Investors
Orbimed
Tech stack
DiviGaugesGodaddyGoogle Font ApiHstsHttp/3
#5
Series A · Westlake Village, California · founded 2022$37.4Mraised▾
Series A · Westlake Village, California · founded 2022
Provider of cold chain logistics services for biopharma sector
Fliar Intelligence Index™ 35how this company ranks against its industry peers
Patents
top 28%Funding
top 32%Innovation
top 34%News
top 39%Moat
top 45%Tech
bottom 46%Patents: 28 patents matched (strict assignee match) · 26 filings since 2022 vs 2 in 2017-21 · Latest publication 2026
Funding: Raised $37.4M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) · Last round Series A (May 2026)
Innovation: 28 patents (top 43% of patent-holders) · 26 filings since 2022 vs 2 in 2017-21
Audience (LinkedIn): 1k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public)
Activity (LinkedIn): 3 product launches · 1 awards announced in 12 mo
Funding rounds
- Dec 2025Series A$16.5M
- Jun 2025Series A$20.9M
- Feb 2023Seed—
Founders & team
Investors
Carrier, Cardinal Health, Amgen, TDF Ventures, Gozde Tech Ventures
#6
Acquired · Piscataway, New Jersey · founded 2010 · 235 employees$222.3Mraised▾
Acquired · Piscataway, New Jersey · founded 2010 · 235 employees
Developer of biosimilar medicines. It is an integrated biopharmaceutical company with capabilities in R&D, clinical, manufacturing, regulatory, and intellectual property.
Fliar Intelligence Index™ 76how this company ranks against its industry peers
Innovation
top 12%Patents
top 17%News
top 20%Partners
top 21%Funding
top 24%Talent
top 27%Innovation: 284 patents (top 8% of patent-holders) · 188 filings since 2022 vs 95 in 2017-21
Patents: 284 patents matched (strict assignee match) · 188 filings since 2022 vs 95 in 2017-21 · Latest publication 2026
News: 12 BI events in 12 mo (of 24 tracked, 4 types) · +100% YoY · 8 high-value events (IPO/M&A/funding/contracts) in 12 mo
Funding rounds
- Dec 2025Conventional Debt$72.3M
- Apr 2025Conventional Debt$150M
Founders & team
Investors
GoldenTree
Tech stack
CloudflareGoogle Font ApiGoogle Hosted LibrariesHstsHttp/3Jquery
#7
Series B · Seattle, Washington · founded 2020 · 14 employees$70Mraised▾
Series B · Seattle, Washington · founded 2020 · 14 employees
Developer of engineered cell-based therapeutics to restore vision. The company is advancing cell-based therapies and in vivo reprogramming to restore vision loss caused by the deterioration of functional tissue for people with degenerative ocular diseases.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Funding
top 23%Talent
top 23%Moat
top 31%Growth
top 33%Tech
top 49%News
top 49%Funding: Raised $70.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series B (Jan 2026)
Talent: 8 named leaders on record · 8 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 10 curated direct competitors tracked
Funding rounds
- Jan 2026Conventional Debt$150M
- Jan 2026Series B$85M
- Jul 2023Series A$70M
- 2021Seed—
Founders & team
Investors
British Patient Capital, F-Prime Capital, Sofinnova Partners, Qiming, Eight Roads Ventures, UCL Technology Fund
Tech stack
AccessibeAnime.JsCookieyesCore-JsElementorFastly
#8
Series A · Seattle, Washington · founded 2022 · 34 employees$85Mraised▾
Series A · Seattle, Washington · founded 2022 · 34 employees
InduPro is a biotechnology company that focuses on bringing proteins on the cell surface closer together, manipulating their interactions to open up new possibilities for treating various conditions. They have a multidisciplinary team with backgrounds in pharma, academia, and biotech, and they are dedicated to impacting patients' lives through innovative drug development.
Fliar Intelligence Index™ 21how this company ranks against its industry peers
Funding
top 29%Tech
bottom 40%Global
bottom 36%Market
bottom 22%Funding: Raised $85.0M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) · Last round Series A (Dec 2025)
Tech: 20 technologies across 2/8 capability areas · Cloud: Cloudflare · Security: Cloudflare Bot Management, Http/3
Global: Investors from 1 country beyond United States
Audience (LinkedIn): 4k LinkedIn followers
Activity (LinkedIn): 2 partnerships (incl. Lilly) announced in 12 mo
Funding rounds
- Dec 2025Series A—
- Jun 2024Series A$85M
Investors
The Column Group, Vida Ventures, MRLV, Emerson Collective, Euclidean Capital, Sanofi
Tech stack
CdnjsCloudflareCloudflare Bot ManagementD3Fullpage.JsGodaddy
#9
Series A · Belmont, Massachusetts · founded 2020$21Mraised▾
Series A · Belmont, Massachusetts · founded 2020
Developer of autologous neuron replacement medicines for neurodegenerative disorders. The company focuses on developing medicines to replace lost neurons. It aims to restore function for Parkinson’s disease and other neurodegenerative disorders.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Talent
top 28%Funding
top 45%Innovation
top 49%Patents
top 49%Global
bottom 42%Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Funding: Raised $21.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series A (Mar 2026)
Innovation: 20 patents (top 51% of patent-holders)
Funding rounds
- Mar 2026Grant (prize money)—
- Mar 2026Series A$21M
Founders & team
Investors
Byers Capital, Neuro VC
#10
Seed · Lexington, Massachusetts · founded 2023$56Mraised▾
Seed · Lexington, Massachusetts · founded 2023
It has launched with $56 million in funding to advance its covalent medicines platform, which targets histidine, tyrosine, and lysine binding pockets in disease-causing proteins. The company aims to expand the boundaries of drug discovery with its innovative covalent platform.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
Funding
top 33%Talent
bottom 49%Global
bottom 38%News
bottom 18%Funding: Raised $56.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) · Last round Seed (Dec 2025)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Global: Investors from 3 countries beyond United States
Funding rounds
- Dec 2025Seed$6.6M
- Sep 2023Seed$56M
Founders & team
Investors
RA Capital Management, Droia Ventures, Novartis Venture Fund, The Mark Foundation, KB Investment, Eisai Innovation
#11
Series A · Boston, Massachusetts · founded 2022$153Mraised▾
Series A · Boston, Massachusetts · founded 2022
Superluminal Medicines Inc. is a biotechnology research company based in Boston, Massachusetts. They specialize in generative biological and chemical solutions for drug discovery programs. The company recently launched with a $33 million seed round to fuel its drug discovery engine and pipeline of small molecule therapeutics.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
Funding
top 21%Talent
top 38%Market
bottom 44%Partners
bottom 35%Global
bottom 29%News
bottom 15%Funding: Raised $153M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series A (Aug 2025)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Market: 1 contract event in 12 mo
Audience (LinkedIn): 5k LinkedIn followers
Activity (LinkedIn): 1 partnerships · 1 awards (incl. Eli Lilly & Company) announced in 12 mo
Funding rounds
- Aug 2025Series A$5M
- Aug 2024Series A$120M
- Aug 2023Seed$33M
Founders & team
Investors
RA Capital Management, Nvidia, Insight Partners, Gaingels, Catalio Capital Management, Lilly
#12
Late Stage · Philadelphia, Pennsylvania · founded 1997 · 4300 employees$205Mraised▾
Late Stage · Philadelphia, Pennsylvania · founded 1997 · 4300 employees
Provider of clinical & commercial supply chain and packaging solutions
Fliar Intelligence Index™ 84how this company ranks against its industry peers
Funding
top 22%Tech
top 24%Innovation
top 25%Product
top 30%Growth
top 35%Market
top 38%Funding: Raised $205M across 1 rounds · 1 rounds over 14 yrs (0.1/yr) · Last round PE (Jul 2025)
Tech: 48 technologies across 5/8 capability areas · Cloud: Amazon Ses, Amazon Web Services · Devops: Nginx
Innovation: 4 product lines
Audience (LinkedIn): 91k LinkedIn followers — 7.1% of this cohort's audience · 65 engagements/post (2.2× cohort median)
Activity (LinkedIn): 2 expansions announced in 12 mo
Funding rounds
- Jul 2025PE—
- 2016PE—
- May 2013Conventional Debt$205M
- 2012PE—
Founders & team
Investors
Thomas H Lee Partners, Frazier Healthcare Partners, Kohlberg & Company, Mubadala, Bain Capital, Partners Group
Tech stack
Amazon SesAmazon Web ServicesApple Icloud MailBootstrapCloudflareCloudflare Bot Management
Funding & investor landscape
$20.3Btotal disclosed funding
483companies funded
1,391disclosed rounds
3rounds last 90 days
Most active investors
Notable founders
Rahul Singhvi
ex-Co-Founder · Resilience
Errik Anderson
CEO · Alloy Therapeutics
Tassos Gianakakos
Co-Founder & CEO · Kardigan
John Zehner
CEO · SpectronRx
Clay Alexander
Founder & Chairman · Ember LifeSciences
Chintu Patel
Co-Founder · Kashiv BioSciences
Chirag Patel
Co-Founder · Kashiv BioSciences
Jose Sahel
Co-Founder · Tenpoint Therapeutics
Lyndon Cruz
Co-Founder · Tenpoint Therapeutics
Ole Isacson
Co-Founder · Oryon
Nikola Kojic
Co-Founder & Chief Innovation Officer · Oryon
Kleem Chaudhary
President & Chief Executive Officer · Hyku Biosciences
Prism market signals · United States · country-scoped Prism corpus, 1,368,075 docs
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · United States
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
research sentiment over time
200820162026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and steady — the enthusiastic (strongly-positive) share moved 44% → 42% across 2008–2026.
top research entities
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
leading researchers
Stylianos Chatzimanolis · TARIK DEDOVIC · KATH-RYN ANN F. HANKINS · Christoforos Pavlou · Giannis Bolanakis · Ashley R Tetens · Tyler Findlay · Jordyn Craig-Schwartz
▲
Breakthroughs2,038 · 33%
▼ 41%→30% share
▼0.7× share momentum0 median citations71% since 2021mostly empirical
Gene-focused breakthrough research surged 5× (33→164 papers), cementing it as the dominant discovery sub-topic in US biotech.
rising sub-themes (early→recent)
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
Newly emergingIdentification (biology) 0→18 · Function (biology) 0→18 · Reporter gene 0→16
Landmark U1 snRNP regulates cancer cell migration and invasion in vitro · 7,224 cites
◆
Advancements2,118 · 34%
▲ 29%→35% share
▲1.2× share momentum0 median citations80% since 2021mostly empirical
Cell culture and gene expression advancements each jumped 3→62 papers, signaling intensifying applied translation of gene findings.
rising sub-themes (early→recent)
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
Newly emergingIdentification (biology) 0→27 · Probiotic 0→24 · Cultivar 0→23
Landmark Using Deep Learning for Image-Based Plant Disease Detection · 4,262 cites
▼
Concerns1,006 · 16%
▼ 17%→15% share
▼0.9× share momentum0 median citations73% since 2021mostly empirical
Antibiotic resistance concern papers tripled (15→45), while agriculture worries also rose sharply (19→58) across US institutions.
rising sub-themes (early→recent)
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Newly emergingQuality (philosophy) 0→27 · Animal health 0→14 · Integrated pest management 0→13
Landmark The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate · 8,812 cites
RESEARCH HOTSPOTS · United States
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Boston351 · +0.52
New York319 · +0.47
SF Bay Area235 · +0.57
Philadelphia115 · +0.60
San Diego101 · +0.59
Seattle95 · +0.46
Chicago95 · +0.57
Los Angeles93 · +0.61
Pittsburgh65 · +0.54
Ann Arbor65 · +0.58
PATENT SIGNAL · United States
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
457,918 filings8,000 assigneespeak 51616/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
- Genentech18113
- UNIV California17975
- Regeneron Pharma16083
- Amgen10515
- Monsanto Technology9755
- UNIV Pennsylvania8528
- Harvard College7464
- UNIV Texas7384
Common questions
How many Biopharma Outsourcing companies are there in United States?
Radar tracks 2542 indexable Biopharma Outsourcing companies headquartered in United States that meet our profile-completeness bar.
What is the total funding raised by Biopharma Outsourcing companies in United States?
The Biopharma Outsourcing companies in United States on this list have raised a combined $20.3B in disclosed equity funding across 483 funded companies.
Which is the highest-funded Biopharma Outsourcing company in United States?
Resilience is the highest-funded Biopharma Outsourcing company in United States, with $2B in disclosed equity funding.
How many Biopharma Outsourcing companies in United States are funded?
483 of the 2542 Biopharma Outsourcing companies in United States on this list have disclosed at least one equity funding round.
How many Biopharma Outsourcing unicorns are there in United States?
1 Biopharma Outsourcing company in United States on this list is valued at $1B or more.
Who are the top investors in United States Biopharma Outsourcing companies?
The most active investors in United States Biopharma Outsourcing companies on this list include HHS, National Science Foundation, NIH, Europa, Ampersand Capital.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.